JP2023515528A5 - - Google Patents
Info
- Publication number
- JP2023515528A5 JP2023515528A5 JP2022550934A JP2022550934A JP2023515528A5 JP 2023515528 A5 JP2023515528 A5 JP 2023515528A5 JP 2022550934 A JP2022550934 A JP 2022550934A JP 2022550934 A JP2022550934 A JP 2022550934A JP 2023515528 A5 JP2023515528 A5 JP 2023515528A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062982872P | 2020-02-28 | 2020-02-28 | |
| US62/982,872 | 2020-02-28 | ||
| US202063051756P | 2020-07-14 | 2020-07-14 | |
| US63/051,756 | 2020-07-14 | ||
| PCT/US2021/019502 WO2021173740A1 (en) | 2020-02-28 | 2021-02-25 | Methods of treating primary progressive multiple sclerosis using an inhibitor of bruton's tyrosine kinase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023515528A JP2023515528A (ja) | 2023-04-13 |
| JPWO2021173740A5 JPWO2021173740A5 (https=) | 2024-03-04 |
| JP2023515528A5 true JP2023515528A5 (https=) | 2024-03-04 |
Family
ID=74885089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550934A Withdrawn JP2023515528A (ja) | 2020-02-28 | 2021-02-25 | ブルトン型チロシンキナーゼの阻害剤を使用する一次性進行型多発性硬化症の治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230091561A1 (https=) |
| EP (1) | EP4110339A1 (https=) |
| JP (1) | JP2023515528A (https=) |
| KR (1) | KR20220148826A (https=) |
| CN (1) | CN115175682A (https=) |
| AU (1) | AU2021227674A1 (https=) |
| BR (1) | BR112022017102A2 (https=) |
| CA (1) | CA3170685A1 (https=) |
| CL (1) | CL2022002317A1 (https=) |
| IL (1) | IL295476A (https=) |
| MX (1) | MX2022010513A (https=) |
| TW (1) | TWI899163B (https=) |
| WO (1) | WO2021173740A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021249129A1 (en) | 2020-04-03 | 2022-10-20 | F. Hoffmann-La Roche Ag | Methods of treating relapsing Multiple Sclerosis using an inhibitor of Bruton's tyrosine kinase |
| CN114028393B (zh) * | 2021-11-07 | 2023-07-18 | 天津医科大学 | 阿帕替尼在制备治疗多发性硬化症药物的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA111756C2 (uk) | 2011-11-03 | 2016-06-10 | Ф. Хоффманн-Ля Рош Аг | Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона |
| EP4732904A2 (en) * | 2015-10-06 | 2026-04-29 | F. Hoffmann-La Roche AG | Method for treating multiple sclerosis |
| EP4049660B1 (en) | 2016-02-29 | 2025-02-19 | F. Hoffmann-La Roche AG | Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase |
| CN110382052A (zh) * | 2017-03-26 | 2019-10-25 | Mapi医药公司 | 用于治疗进展型形式的多发性硬化症的格拉替雷储库系统 |
| MX2021000094A (es) * | 2018-07-20 | 2021-03-25 | Merck Patent Gmbh | Compuesto de amino-pirimidina sustituido para usarse en un metodo para tratamiento y prevencion de esclerosis multiple. |
| AU2021249129A1 (en) * | 2020-04-03 | 2022-10-20 | F. Hoffmann-La Roche Ag | Methods of treating relapsing Multiple Sclerosis using an inhibitor of Bruton's tyrosine kinase |
-
2021
- 2021-02-25 MX MX2022010513A patent/MX2022010513A/es unknown
- 2021-02-25 CN CN202180017387.XA patent/CN115175682A/zh active Pending
- 2021-02-25 TW TW110106714A patent/TWI899163B/zh active
- 2021-02-25 BR BR112022017102A patent/BR112022017102A2/pt unknown
- 2021-02-25 EP EP21712677.0A patent/EP4110339A1/en active Pending
- 2021-02-25 CA CA3170685A patent/CA3170685A1/en active Pending
- 2021-02-25 US US17/905,121 patent/US20230091561A1/en active Pending
- 2021-02-25 IL IL295476A patent/IL295476A/en unknown
- 2021-02-25 WO PCT/US2021/019502 patent/WO2021173740A1/en not_active Ceased
- 2021-02-25 JP JP2022550934A patent/JP2023515528A/ja not_active Withdrawn
- 2021-02-25 KR KR1020227030440A patent/KR20220148826A/ko active Pending
- 2021-02-25 AU AU2021227674A patent/AU2021227674A1/en active Pending
-
2022
- 2022-08-24 CL CL2022002317A patent/CL2022002317A1/es unknown